Your search for ‘Smart & Biggar’ returned 2,497 results

On March 7, 2024, Health Canada published a Memorandum of Understanding (MOU) with the Competition Bureau (together, Participants) to advance their mutual interests and develop a framework...

In July 2012, Health Canada released its position on whether evidence existed to support two new health claims.

On June 10, 2025, Health Canada launched a consultation on its Draft Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs...

As previously reported, in December 2024, Health Canada published its agile licensing amendments to the Food and Drug Regulations (FDRs).

Health Canada has proposed amendments to the Medical Devices Regulations (Regulations) that would expand the regulatory framework for COVID-19 medical devices to apply...

Innovative Solutions Canada currently has several open funding opportunities for quantum-related technologies that may provide up to $1.15 million CAD to eligible innovators towards the development of a prototype.

On February 15, 2023, Regulations Amending Certain Regulations Concerning the Sale of Drugs (Public or Canadian Armed Forces Health Emergencies) came into force.

The Government of Canada will soon require food manufacturers to add a front-of-package (FOP) nutrition symbol on prepackaged foods that are high in sodium, sugars, and /or saturated fat.

Health Canada has published comprehensive amendments to drug and medical device shortage regulations, introducing expanded reporting requirements, extended expiration date authorities, and enhanced exceptional importation frameworks. The new measures grant the Minister of Health broader powers to prevent and respond to supply disruptions while requiring manufacturers to provide 12-month advance notice of discontinuations.

On February 16, 2024, the Minister of Health tabled the 2022 Annual Report of the Patented Medicine Prices Review Board (PMPRB).

It is important for innovative drug companies to take advantage of available exclusivities, to ensure that they can recoup investment from the costly drug...

On December 18, 2020, the Quebec Superior Court issued its decision from a constitutional challenge to the Patented Medicine Prices Review Board (PMPRB) provisions of the ...

Health Canada has released the first look at what the packaging and labelling provisions of the proposed regulations might look like.

The Supreme Court of Canada has granted Sanis Health, Shoppers Drug Mart, Sandoz Canada, and McKesson Canada leave to appeal Sandoz Canada v British Columbia, 2023 BCCA 306.

The UPS company doesn't just deliver, or occasionally lose, your courier parcels — it also runs sophisticated storage warehouses.

COVID-19 remained an area of rapid innovation in 2021. Regulators continued rapid approval of new drugs, vaccines and diagnostics.

A new judicial test has likely established a new commercial standard for determining RAND royalty rates.

The last few years have seen an increase in the number of decisions from the Federal and Ontario courts addressing contempt of court in copyright disputes.